-
1
-
-
48249125791
-
Malignant gliomas in adults
-
Wen P, Kesari S. Malignant gliomas in adults. New Engl J Med 2008;359:492-507.
-
(2008)
New Engl J Med
, vol.359
, pp. 492-507
-
-
Wen, P.1
Kesari, S.2
-
3
-
-
77956224494
-
Oxygen in stem cell biology: A critical component of the stem cell niche
-
Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 2010;7:150-161.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 150-161
-
-
Mohyeldin, A.1
Garzon-Muvdi, T.2
Quinones-Hinojosa, A.3
-
4
-
-
77649273107
-
Hypoxia inducible factors in cancer stem cells
-
Heddleston JM, Li Z, Lathia JD et al. Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010;102:789-795.
-
(2010)
Br J Cancer
, vol.102
, pp. 789-795
-
-
Heddleston, J.M.1
Li, Z.2
Lathia, J.D.3
-
5
-
-
79251591038
-
Glioblastoma, cancer stem cells and hypoxia
-
Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 2011;21:119-129.
-
(2011)
Brain Pathol
, vol.21
, pp. 119-129
-
-
Bar, E.E.1
-
6
-
-
65649115060
-
Hypoxia helps glioma to fight therapy
-
Amberger-Murphy V. Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 2009;9:381-390.
-
(2009)
Curr Cancer Drug Targets
, vol.9
, pp. 381-390
-
-
Amberger-Murphy, V.1
-
7
-
-
34247527730
-
Hypoxia-inducible factors, stem cells, and cancer
-
Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007;129: 465-472.
-
(2007)
Cell
, vol.129
, pp. 465-472
-
-
Keith, B.1
Simon, M.C.2
-
8
-
-
65249131228
-
Brain tumor hypoxia: Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
-
Jensen R. Brain tumor hypoxia: Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009;92:317-335.
-
(2009)
J Neurooncol
, vol.92
, pp. 317-335
-
-
Jensen, R.1
-
9
-
-
65749106405
-
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
-
Li Z, Bao S, Wu Q et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009;15:501-513.
-
(2009)
Cancer Cell
, vol.15
, pp. 501-513
-
-
Li, Z.1
Bao, S.2
Wu, Q.3
-
10
-
-
0030789242
-
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
-
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
-
(1997)
Nat Med
, vol.3
, pp. 730-737
-
-
Bonnet, D.1
Dick, J.E.2
-
11
-
-
4944250781
-
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
-
Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-7021.
-
(2004)
Cancer Res
, vol.64
, pp. 7011-7021
-
-
Galli, R.1
Binda, E.2
Orfanelli, U.3
-
12
-
-
9244241576
-
Identification of human brain tumour initiating cells
-
Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
-
(2004)
Nature
, vol.432
, pp. 396-401
-
-
Singh, S.K.1
Hawkins, C.2
Clarke, I.D.3
-
13
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
-
14
-
-
69249139924
-
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens
-
Kelly JJ, Stechishin O, Chojnacki A et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. STEM CELLS 2009;27:1722-1733.
-
(2009)
Stem Cells
, vol.27
, pp. 1722-1733
-
-
Kelly, J.J.1
Stechishin, O.2
Chojnacki, A.3
-
15
-
-
63849225752
-
Human glioblastoma-derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
-
Wakimoto H, Kesari S, Farrell CJ et al. Human glioblastoma-derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 2009;69:3472-3481.
-
(2009)
Cancer Res
, vol.69
, pp. 3472-3481
-
-
Wakimoto, H.1
Kesari, S.2
Farrell, C.J.3
-
16
-
-
70350225829
-
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
-
Heddleston JM, Li Z, McLendon RE et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009;8:3274-3284.
-
(2009)
Cell Cycle
, vol.8
, pp. 3274-3284
-
-
Heddleston, J.M.1
Li, Z.2
McLendon, R.E.3
-
17
-
-
64149101418
-
Tumor initiating cells in malignant gliomas: Biology and implications for therapy
-
Hadjipanayis CG. Tumor initiating cells in malignant gliomas: Biology and implications for therapy. J Mol Med 2009;87:363-374.
-
(2009)
J Mol Med
, vol.87
, pp. 363-374
-
-
Hadjipanayis, C.G.1
-
18
-
-
68549104117
-
The role of oxygen in regulating neural stem cells in development and disease
-
Panchision DM. The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 2009;220:562-568.
-
(2009)
J Cell Physiol
, vol.220
, pp. 562-568
-
-
Panchision, D.M.1
-
19
-
-
77956503727
-
Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres
-
Bar EE, Lin A, Mahairaki V et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010;177:1491-1502.
-
(2010)
Am J Pathol
, vol.177
, pp. 1491-1502
-
-
Bar, E.E.1
Lin, A.2
Mahairaki, V.3
-
21
-
-
77950838848
-
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2
-
Seidel S, Garvalov BK, Wirta V et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2. Brain 2010;133:983-995.
-
(2010)
Brain
, vol.133
, pp. 983-995
-
-
Seidel, S.1
Garvalov, B.K.2
Wirta, V.3
-
22
-
-
70449687092
-
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
-
Soeda A, Park M, Lee D et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene 2009;28:3949-3959.
-
(2009)
Oncogene
, vol.28
, pp. 3949-3959
-
-
Soeda, A.1
Park, M.2
Lee, D.3
-
23
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
-
(2006)
Nature
, vol.444
, pp. 756-760
-
-
Bao, S.1
Wu, Q.2
McLendon, R.E.3
-
24
-
-
78751649494
-
Cancer stem cells: The final frontier for glioma virotherapy
-
Dey M, Ulasov IV, Tyler MA et al. Cancer stem cells: The final frontier for glioma virotherapy. Stem Cell Rev 2011;7:119-129.
-
(2011)
Stem Cell Rev
, vol.7
, pp. 119-129
-
-
Dey, M.1
Ulasov, I.V.2
Tyler, M.A.3
-
25
-
-
44649137314
-
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors
-
Beier D, Wischhusen J, Dietmaier W et al. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 2008;18:370-377.
-
(2008)
Brain Pathol
, vol.18
, pp. 370-377
-
-
Beier, D.1
Wischhusen, J.2
Dietmaier, W.3
-
26
-
-
33845671339
-
Analysis of gene expression and chemoresistance of CD133 cancer stem cells in glioblastoma
-
Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133 cancer stem cells in glioblastoma. Mol Cancer 2006;5:67.
-
(2006)
Mol Cancer
, vol.5
, pp. 67
-
-
Liu, G.1
Yuan, X.2
Zeng, Z.3
-
27
-
-
40749155451
-
Stem cell marker CD133 affects clinical outcome in glioma patients
-
Zeppernick F, Ahmadi R, Campos B et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14:123-129.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 123-129
-
-
Zeppernick, F.1
Ahmadi, R.2
Campos, B.3
-
28
-
-
34249332411
-
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
-
Beier D, Hau P, Proescholdt M et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007;67:4010-4015.
-
(2007)
Cancer Res
, vol.67
, pp. 4010-4015
-
-
Beier, D.1
Hau, P.2
Proescholdt, M.3
-
29
-
-
77950502115
-
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma
-
Chen R, Nishimura MC, Bumbaca SM et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010; 17:362-375.
-
(2010)
Cancer Cell
, vol.17
, pp. 362-375
-
-
Chen, R.1
Nishimura, M.C.2
Bumbaca, S.M.3
-
30
-
-
12944315014
-
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial
-
Markert JM, Medlock MD, Rabkin SD et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial. Gene Ther 2000;7:867-874.
-
(2000)
Gene Ther
, vol.7
, pp. 867-874
-
-
Markert, J.M.1
Medlock, M.D.2
Rabkin, S.D.3
-
31
-
-
27944433469
-
Oncolytic viral therapies: The clinical experience
-
Aghi M, Martuza RL. Oncolytic viral therapies: The clinical experience. Oncogene 2005; 24:7802-7816.
-
(2005)
Oncogene
, vol.24
, pp. 7802-7816
-
-
Aghi, M.1
Martuza, R.L.2
-
32
-
-
58149237728
-
Phase Ib trial of mutant herpes simplex virus G207 inoculated preand post-tumor resection for recurrent GBM
-
Markert JM, Liechty PG, Wang W et al. Phase Ib trial of mutant herpes simplex virus G207 inoculated preand post-tumor resection for recurrent GBM. Mol Ther 2009;17: 199-207.
-
(2009)
Mol Ther
, vol.17
, pp. 199-207
-
-
Markert, J.M.1
Liechty, P.G.2
Wang, W.3
-
33
-
-
58149214278
-
Hypoxia enhances the replication of oncolytic herpes simplex virus
-
Aghi MK, Liu TC, Rabkin S, et al. Hypoxia enhances the replication of oncolytic herpes simplex virus. Mol Ther 2009;17:51-56.
-
(2009)
Mol Ther
, vol.17
, pp. 51-56
-
-
Aghi, M.K.1
Liu, T.C.2
Rabkin, S.3
-
34
-
-
0035933088
-
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
-
Todo T, Martuza RL, Rabkin SD et al. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci USA 2001;98: 6396-6401.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 6396-6401
-
-
Todo, T.1
Martuza, R.L.2
Rabkin, S.D.3
-
35
-
-
28244502278
-
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system
-
Fukuhara H, Ino Y, Kuroda T et al. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system. Cancer Res 2005;65:10663-10668.
-
(2005)
Cancer Res
, vol.65
, pp. 10663-10668
-
-
Fukuhara, H.1
Ino, Y.2
Kuroda, T.3
-
36
-
-
0025876227
-
Regulation of herpes simplex virus true late gene expression: Sequences downstream from the US11 TATA box inhibit expression from an unreplicated template
-
Kibler PK, Duncan J, Keith BD et al. Regulation of herpes simplex virus true late gene expression: Sequences downstream from the US11 TATA box inhibit expression from an unreplicated template. J Virol 1991;65:6749-6760.
-
(1991)
J Virol
, vol.65
, pp. 6749-6760
-
-
Kibler, P.K.1
Duncan, J.2
Keith, B.D.3
-
37
-
-
0028149276
-
Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cisacting downstream activation sequence is mediated by a cellular transcription factor
-
Guzowski JF, Singh J, Wagner EK. Transcriptional activation of the herpes simplex virus type 1 UL38 promoter conferred by the cisacting downstream activation sequence is mediated by a cellular transcription factor. J Virol 1994;68:7774-7789.
-
(1994)
J Virol
, vol.68
, pp. 7774-7789
-
-
Guzowski, J.F.1
Singh, J.2
Wagner, E.K.3
-
38
-
-
33750074397
-
FlipFlop HSV-BAC: Bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases
-
Kuroda T, Martuza RL, Todo T et al. FlipFlop HSV-BAC: Bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases. BMC Biotechnol 2006;6:40.
-
(2006)
BMC Biotechnol
, vol.6
, pp. 40
-
-
Kuroda, T.1
Martuza, R.L.2
Todo, T.3
-
39
-
-
79957881687
-
A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells
-
Kanai R, Wakimoto H, Martuza RL et al. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells. Clin Cancer Res 2011;17:3686-3696.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3686-3696
-
-
Kanai, R.1
Wakimoto, H.2
Martuza, R.L.3
-
40
-
-
65749087298
-
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma
-
Laks DR, Masterman-Smith M, Visnyei K et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. STEM CELLS 2009;27:980-987.
-
(2009)
Stem Cells
, vol.27
, pp. 980-987
-
-
Laks, D.R.1
Masterman-Smith, M.2
Visnyei, K.3
-
41
-
-
56349113871
-
CD133 is a marker of bioenergetic stress in human glioma
-
Griguer CE, Oliva CR, Gobin E et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS One 2008;3:e3655.
-
(2008)
PLoS One
, vol.3
-
-
Griguer, C.E.1
Oliva, C.R.2
Gobin, E.3
-
42
-
-
78650705036
-
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
-
Pallini R, Ricci-Vitiani L, Montano N et al. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 2011;117:162-174.
-
(2011)
Cancer
, vol.117
, pp. 162-174
-
-
Pallini, R.1
Ricci-Vitiani, L.2
Montano, N.3
-
43
-
-
69949134899
-
Glioblastoma formation from cell population depleted of Prominin1-expressing cells
-
Nishide K, Nakatani Y, Kiyonari H et al. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS One 2009;4:e6869.
-
(2009)
PLoS One
, vol.4
-
-
Nishide, K.1
Nakatani, Y.2
Kiyonari, H.3
-
44
-
-
78649900502
-
Insight into the complex regulation of CD133 in glioma
-
Campos B, Herold-Mende CC. Insight into the complex regulation of CD133 in glioma. Int J Cancer 2011;128:501-510.
-
(2011)
Int J Cancer
, vol.128
, pp. 501-510
-
-
Campos, B.1
Herold-Mende, C.C.2
-
46
-
-
33947428335
-
Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor
-
Mulvey M, Arias C, Mohr I. Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor. J Virol 2007;81:3377-3390.
-
(2007)
J Virol
, vol.81
, pp. 3377-3390
-
-
Mulvey, M.1
Arias, C.2
Mohr, I.3
-
47
-
-
0036837864
-
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α
-
Koumenis C, Naczki C, Koritzinsky M et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α. Mol Cell Biol 2002;22: 7405-7416.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 7405-7416
-
-
Koumenis, C.1
Naczki, C.2
Koritzinsky, M.3
-
48
-
-
73949120145
-
1 arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2α phosphorylation
-
1 arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2α phosphorylation. Neoplasia 2010;12:61-68.
-
(2010)
Neoplasia
, vol.12
, pp. 61-68
-
-
Liu, Y.1
Laszlo, C.2
Liu, Y.3
-
49
-
-
68049110425
-
Hypoxia enhances the replication of oncolytic herpes simplex virus in p53 breast cancer cells
-
Fasullo M, Burch AD, Britton A. Hypoxia enhances the replication of oncolytic herpes simplex virus in p53 breast cancer cells. Cell Cycle 2009;8:2194-2197.
-
(2009)
Cell Cycle
, vol.8
, pp. 2194-2197
-
-
Fasullo, M.1
Burch, A.D.2
Britton, A.3
-
50
-
-
42649106141
-
Hypoxia induces protection against etoposideinduced apoptosis: Molecular profiling of changes in gene expression and transcription factor activity
-
Sermeus A, Cosse JP, Crespin M et al. Hypoxia induces protection against etoposideinduced apoptosis: Molecular profiling of changes in gene expression and transcription factor activity. Mol Cancer 2008;7:27.
-
(2008)
Mol Cancer
, vol.7
, pp. 27
-
-
Sermeus, A.1
Cosse, J.P.2
Crespin, M.3
|